Disease severity | Moderate | P* | Severe (severe + critically severe) | P** | ||
---|---|---|---|---|---|---|
COVID-19 n = 140 | SN-CAP n = 97 | COVID-19n = 164 | SN-CAP n = 41 | |||
White blood cell count, x109/L | 5.72 (2.03) | 7.67 (3.1) | <0.01 | 7.11 (3.58) | 9.2 (5.85) | <0.01 |
Lymphocyte count, x109/L | 1.44 (0.6) | 1.27 (0.65) | 0.04 | 0.96 (0.75) | 1.06 (0.75) | 0.43 |
Lymphocyte ratio, % | 26.59 (10.17) | 18 (0.95) | <0.01 | 15.39 (9.82) | 13.85 (10.3) | 0.37 |
Neutrophil count, x109/L | 3.77 (1.82) | 5.62 (2.74) | <0.01 | 5.73 (3.55) | 7.71 (5.99) | <0.01 |
Platelet count, x109/L | 223 (76) | 187 (81) | 0.01 | 188 (86) | 203 (90) | 0.33 |
C-Reactive protein, mg/L | 16 (30) | 34.88 (43.25) | <0.01 | 67.75 (73.93) | 53.4 (63.1) | 0.26 |
NLR, % | 3.1 (2.41) | 6.42 (8.14) | <0.01 | 11.66 (27.66) | 13.6 (19) | 0.67 |
PLR, % | 181 (97) | 193 (120) | 0.42 | 262 (196) | 309 (248) | 0.2 |
P-value indicates differences between COVID-19 and SN-CAP; P* indicates differences of moderate pneumonia between COVID-19 and SN-CAP; P** indicates differences between COVID-19 severe + critically severe group and SN-CAP severe group.
P < 0.05 was considered statistically significant.